Skip to main content
Premium Trial:

Request an Annual Quote

Protea Licenses Cardiovascular Biomarker Tech from Hopkins

NEW YORK (GenomeWeb News) – Protea Biosciences has licensed technology from Johns Hopkins University that it plans to use to develop tools for improving treatment of myocardial ischemia, the company said today.

The company has licensed technology developed in the lab of Hopkins researcher Jennifer Van Eyk that has been used to identify proteins bound to human serum albumin that are associated with cardiovascular disease.

Steve Turner, Protea's CEO, said in a statement that "there are many more proteins carried by albumin, as well as changes in the albumin itself, that have the potential to yield important new data for identifying specific types of heart disease."

The exclusive license gives the Morgantown, WV-based company the rights to apply the technology to develop new products for analyzing the albumin protein, "and to create new cardiovascular disease management tools for improving the treatment of myocardial ischemia."

The company plans to develop a rapid test that would enable physicians to determine if a patient has myocardial ischemia, which would improve with medication, or ischemia related to a myocardial infarction, which would require emergency surgery. In such cases, the company said, the first hour after the onset of ischemia is the most critical for making treatment decisions.

Financial terms of the agreement were not released.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.